Detection of the Mr 110,000 Lung Resistance-related Protein LRP/MVP with Monoclonal Antibodies
The Mr 110,000 lung resistance-related protein (LRP), also termed the major vault protein (MVP), constitutes >70% of subcellular ribonucleoprotein particles called vaults. Overexpression of LRP/MVP and vaults has been linked directly to MDR in cancer cells. Clinically, LRP/MVP expression can be o...
Saved in:
Published in | The journal of histochemistry and cytochemistry Vol. 49; no. 11; pp. 1379 - 1385 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Los Angeles, CA
Histochemical Soc
01.11.2001
SAGE Publications |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The Mr 110,000 lung resistance-related protein (LRP), also termed the major vault protein (MVP), constitutes >70% of subcellular ribonucleoprotein particles called vaults. Overexpression of LRP/MVP and vaults has been linked directly to MDR in cancer cells. Clinically, LRP/MVP expression can be of value to predict response to chemotherapy and prognosis. Monoclonal antibodies (MAbs) against LRP/MVP have played a critical role in determining the relevance of this protein in clinical drug resistance. We compared the applicability of the previously described MAbs LRP-56, LMR-5, LRP, 1027, 1032, and newly isolated MAbs MVP-9, MVP-16, MVP-18, and MVP-37 for the immunodetection of LRP/MVP by immunoblotting analysis and by immunocyto- and histochemistry. The availability of a broader panel of reagents for the specific and sensitive immunodetection of LRP/MVP should greatly facilitate biological and clinical studies of vault-related MDR. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0022-1554 1551-5044 |
DOI: | 10.1177/002215540104901106 |